This content is grounded in peer-reviewed research, clinical guidelines, and established best practices. Claims are reviewed for accuracy and transparency. Learn more about our evidence standards
How Long Does Ketamine Pain Relief Last? From Infusion to Recovery
Safety note: Ketamine can raise blood pressure/heart rate and may cause nausea, dizziness, or dissociation during treatment. Repeated high-dose or unsupervised use is associated with harms (e.g., bladder symptoms). Ketamine for chronic pain should be clinician-supervised, with screening for cardiovascular and psychiatric risks.
For decades, chronic pain has been treated like a fire that never quite goes out — dulled by opioids, managed by patches and pills, but rarely relieved. Then came ketamine. Once known only as an anaesthetic, it has become one of the most talked-about off-label treatments1 for people living with unrelenting pain. Infused in low doses, ketamine doesn’t just mute pain: it appears to reset the nervous system itself, blocking NMDA receptors2 and reducing the brain’s overactive pain signalling.
But the main question remains: how long does ketamine pain relief last? Hours, weeks, or months — the answer, as research shows, depends3 on the dose, the diagnosis, and the body.
Pain Relief Is Time Limited — But Ketamine Might Help
For years, modern pain care has leaned heavily on opioids4: drugs that silence symptoms but often spark dependence, tolerance, and emotional or brain fog. As the limits of that approach became painfully clear, medicine began to search for a gentler alternative. Ketamine, once confined to the operating room, emerged as an unexpected contender. At subanesthetic doses, it interrupts the brain’s pain loops1 and calms the overexcited nerves that keep pain signals stuck in replay.
Ketamine is used off-label1 for a range of chronic pain conditions — complex regional pain syndrome, fibromyalgia, post-surgical nerve pain, treatment-resistant migraine. The evidence behind those uses is uneven, and that unevenness turns out to be the key to the question of how long relief lasts.
How Ketamine Works: Resetting the Pain Pathways
Pain doesn’t just live in the body — it’s “written” into the nervous system. Over time, constant pain signals can leave the brain stuck in a state of “high alert,” a process called central sensitisation6, where even normal sensations begin to register as pain. Ketamine interrupts this cycle by blocking NMDA receptors, the neural amplifiers responsible for that runaway signalling.
Unlike opioids, which mask or numb pain signals, ketamine acts directly7 on the central nervous system, targeting the neural circuits that regulate how pain is processed. By dampening hyperactive pain pathways in the spinal cord and brain, it reduces the sensitivity of nerve cells and helps restore balance to the body’s natural pain control circuits. Ketamine may also influence descending pain modulation and multiple neurotransmitter systems; mechanisms beyond NMDA antagonism are still being clarified. In simpler terms, ketamine helps the brain relearn how to turn down its volume.
At the cellular level, these shifts appear to trigger neuroplastic changes8: the rewiring of connections in pain-processing regions. That’s why, as noted in clinical reviews9, the relief from a single or multi-day infusion can outlast the drug’s presence in the bloodstream. What starts as a 40-minute session can, for some, translate into weeks or even months of pain-free living.
The Therapy Timeline: How Long Does Ketamine Pain Relief Last?
The duration of ketamine’s relief depends on how and to whom it’s given. Some people feel the difference almost instantly, but lose it within days. Others experience weeks or months of calm after a carefully structured course of infusions. Across studies, longer or repeated protocols can be associated with longer-lasting relief in some patients — but responses vary widely, and some people experience little or no sustained benefit.
Minutes to Days — Chemical Effects
The first wave of relief often comes fast. During or shortly after a single IV (intravenous) ketamine infusion, pain levels can drop within minutes10 — a response linked to ketamine’s rapid receptor-level effects and downstream neuromodulation. These effects may last anywhere from a few hours to several days.
In clinical studies and reviews11, some patients experience a noticeable reduction in pain for days to up to 2 weeks after a single infusion, though response varies by condition, dose, and protocol. Though this window narrows when the infusion is short and the dose is low. At this stage, ketamine’s work is mostly chemical, turning down pain signals rather than rewriting them.
Weeks to Months — Neuroplastic Effects
Longer protocols change the timescale, but not for every condition equally. The 2018 consensus guidelines from the American Society of Regional Anesthesia, the American Academy of Pain Medicine and the American Society of Anesthesiologists found moderate evidence for complex regional pain syndrome (CRPS): protocols running four days continuously, or four hours daily over ten days, produced improvements lasting up to twelve weeks. The longest-studied version is a 100-hour continuous infusion, which in one trial of 60 CRPS patients kept pain scores significantly lower through week eleven.
For other conditions, the same panel found weak evidence or none — mixed neuropathic pain, phantom limb pain, postherpetic neuralgia, fibromyalgia, cancer pain, migraine and low back pain. Their conclusion was direct: outside CRPS, there is no evidence supporting intermediate or long-term improvement in pain. And even the CRPS literature is thin; a systematic review of it found no high-quality studies, rating all of them moderate to low.
The most important conversations shaping the future of psychedelics, delivered weekly.
From thought-provoking podcasts and original stories to research breakthroughs and industry news, stay connected to the conversations that matter.
Joined by 12,000+ readers
That gap between the CRPS data and everything else is worth holding onto, because clinical practice often runs ahead of it: multi-day protocols are offered for conditions where the evidence supports only short-term relief. Why the effect outlasts the drug in the bloodstream at all remains a hypothesis rather than a finding. The leading explanation is neuroplastic repair12 — the nervous system forming new, less reactive pathways to pain — which would account for why longer courses appear to buy longer relief, though it has not been demonstrated directly in people with chronic pain.
Up to 6 Months — Integrative Effects
The largest dataset so far comes from Cleveland Clinic, published in October 2025: a retrospective analysis of 1,034 patients3 treated with low-dose ketamine — 0.5 mg/kg over 40 minutes, on five consecutive outpatient days. Between 20 and 46 percent achieved clinically meaningful improvement in daily functioning, sleep and pain management, and gains in pain interference, depression and physical function held across more than six months of follow-up. Serious adverse events did not occur and hallucinations were rare.
Two things belong alongside those numbers. The study was retrospective and had no control group, so it describes what happened to patients who chose this treatment rather than what ketamine does relative to nothing. And 80 percent of them came back for repeat infusions — which suggests the benefit was real enough to return for, and that for most people it needed renewing rather than lasting on its own.
Why Duration Varies So Much
No two patients experience ketamine in quite the same way. Relief depends on a constellation of factors that shape how the brain and body respond to treatment:
- Type of pain: neuropathic and nociplastic pain (like CRPS or fibromyalgia) tend to respond longer8 than nociceptive pain from injury or inflammation.
- Infusion length and dosage: short single sessions bring temporary relief; multi-day or higher-dose infusions can extend9 it for weeks or months.
- Individual neurochemistry: genetic and metabolic differences in NMDA receptor activity and neurotransmitter balance influence13 how long the “reset” holds.
- Supporting care: physical therapy, CBT, mindfulness, and adequate rest help stabilise the nervous system and reinforce pain modulation.
- Maintenance/booster infusions: some protocols10 use repeat infusions in selected patients, but schedules and long-term benefit vary and aren’t standardised across conditions.
Together, these factors determine whether ketamine’s relief fades within days — or unfolds into a lasting, months-long pause from chronic pain.
Beyond Infusions: Oral, Nasal, and Combined Care
IV infusions are the most studied approach in chronic pain protocols. Other forms of ketamine can help maintain or fine-tune its effects:
- Oral ketamine: used in chronic and even pediatric pain. The four-week figure that circulates for oral ketamine deserves a closer look. It comes from a phase 1 dose-finding study in 12 children and young adults14 aged 8 to 21, in which five reported improved pain and three sustained that improvement for up to four weeks after stopping. It is a genuine signal, and the reason oral protocols are being studied at all — but it is three young patients in a safety trial, not an established duration for adults with chronic pain.
- Intranasal ketamine: absorption is fast and the effect is short, which has made it useful in emergency medicine. A meta-analysis of seven trials and 1,760 patients15 found intranasal ketamine non-inferior to intravenous analgesics for acute pain from injuries and renal colic. Its use in chronic pain — including as a bridge for breakthrough pain between infusions — is common in clinical practice but has not been tested in trials, and the emergency-department evidence does not transfer to it.
- Intramuscular or topical forms: these are used, but almost all of the duration data in chronic pain comes from intravenous protocols. For other routes, the published evidence is sparse enough that no reliable duration can be given.
It is important to note that non-IV routes (oral or intranasal) are used in some settings, but evidence for durable chronic pain benefit is more limited than IV protocols, and effects can be shorter and more variable.
Most lasting results come from combined care — pairing ketamine in most convenient forms with physiotherapy, mindfulness, or behavioural therapy to help the nervous system stabilise and retain its new, calmer rhythm.
What Lasts Beyond the Pain Relief
Across dozens of studies — from small pilot trials to thousand-patient reviews — ketamine stands out as a reset button for the nervous system. Its relief can last even months9, yet every dataset agrees on one truth: the effect is transient unless supported. When paired with physical therapy, psychological support, and lifestyle changes, ketamine becomes more than a chemical pause — it becomes a doorway to recalibration.
The evidence suggests that the drug’s real value lies not in how long it lingers in the body, but in what happens afterwards: how the brain learns to stay calm8, how patients regain agency over their pain. Ketamine opens a temporary window of possibility1; what people build through it — movement, sleep, resilience — determines how wide that window stays. Science behind ketamine-assisted therapy can’t promise permanence, but it offers something more radical: a chance to live without pain long enough to remember what living feels like.
FAQ
Most people feel pain relief within minutes to hours after an IV infusion. The first wave of relief is often linked to ketamine’s blockade of NMDA receptors and its calming of overactive nerve pathways.
For many patients, relief lasts a few days to two weeks after a single infusion. Multi-day or repeated infusions — especially for neuropathic pain — can extend benefits to several weeks or even up to 3 months. In large trials, some patients maintained improvement for up to 6 months.
Complex regional pain syndrome has the most consistent evidence for lasting benefit — up to twelve weeks after longer infusion protocols. For other neuropathic and nociplastic conditions, including fibromyalgia, the evidence for durable relief is weak; short-term improvement is often reported, but controlled trials have not shown it holding. Nociceptive pain responds most briefly.
Several factors: The length and dose of infusions (multi-day courses last longer). Individual brain chemistry — people metabolise and respond differently. Supporting care like physiotherapy, CBT, mindfulness, and adequate rest. Maintenance infusions, which can sustain the benefit every few weeks or months.
Yes. Oral ketamine can provide relief for up to 4 weeks after a course, while intranasal ketamine offers short-term relief during flare-ups. Topical and intramuscular forms also exist but are less studied.
In supervised settings the safety record is good. In the Cleveland Clinic series of over 1,000 patients there were no serious adverse events and hallucinations were rare; the usual effects are mild dizziness, nausea and brief dissociation during the infusion. Ketamine does raise blood pressure and heart rate while it is being given, which is why sessions are monitored and why uncontrolled hypertension and significant cardiovascular disease are contraindications. Screening beforehand is part of the protocol.
Expert Board Member
A clear, patient-friendly overview of how long ketamine’s analgesic benefit can last and why it varies by pain type and protocol. The piece is strongest when it links duration to central sensitisation and emphasises the importance of supervised care.
